Could CAR T-Cells tame tough lupus? tiny trial aims to find out
NCT ID NCT07432334
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This early-stage trial will test whether a personalized immune cell therapy called CAR T-cells is safe for 8 adults with severe lupus that hasn't improved with standard treatments. Participants will receive a single infusion of their own genetically modified cells after a short course of chemotherapy. The main goal is to check for side effects, but researchers will also look for signs that the treatment might help control the disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
CD19-targeted CAR T-cells (a type of immune cell therapy made from the patient's own blood cells)
What this could lead to
If it works, this could point toward a new way to control severe lupus that hasn't responded to standard treatments, potentially reducing or eliminating the need for long-term immunosuppressants.
What could go wrong
This is a very early phase 1 trial with only 8 people, so it's mainly checking safety, not effectiveness. CAR T-cell therapy can cause serious side effects like cytokine release syndrome or nerve problems, and it's unknown if it will work for lupus at all.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFRACTORY LUPUS NEPHRITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Vinmec Research Institute of Stem Cell and Gene Technology
Hanoi, 10000, Vietnam
Contact Phone: •••-•••-•••• Email: •••••@•••••